Visual outcome in infants born to drug-misusing mothers prescribed methadone in pregnancy

British Journal of Ophthalmology

Volumn 98, Issue 2, 2014, Pages 238-245

  McGlone, Laura ^a   Hamilton, Ruth ^a,b   McCulloch, Daphne L ^c   MacKinnon, Jane R ^d   Bradnam, Michael ^a,b   Mactier, Helen ^e  

^a ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c GLASGOW CALEDONIAN UNIVERSITY   (United Kingdom)

^d RAIGMORE HOSPITAL   (United Kingdom)

^e UK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ILLICIT DRUG; METHADONE;

ALCOHOLISM; ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DRUG DEPENDENCE; DRUG DEPENDENCE TREATMENT; EVOKED VISUAL RESPONSE; EYE DEVELOPMENT; FEMALE; HIGH RISK PREGNANCY; HUMAN; INFANT; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; NYSTAGMUS; ONSET AGE; PRENATAL DRUG EXPOSURE; PRESCRIPTION; PRIORITY JOURNAL; REFRACTION ERROR; RISK ASSESSMENT; STRABISMUS;

CHILD HEALTH (PAEDIATRICS); DRUGS; ELECTROPHYSIOLOGY;

EVOKED POTENTIALS, VISUAL; EYE DISEASES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; INFANT, NEWBORN; MALE; METHADONE; NARCOTICS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; VISUAL ACUITY;

EID: 84892616248     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjophthalmol-2013-303967     Document Type: Article

References (31)

1. Hidden Harm. The report of the enquiry by the advisory Council on the Misuse of Drugs. London: UK Home Office, 2003. ISBN: 1-88473 035-2.
2. Burns L, Mattick RP, Lim K, et al. Methadone in pregnancy: treatment retention and neonatal outcomes. Addiction 2007; 102: 264-70. (Pubitemid 46096288)
3. Dryden C, Young D, Hepburn M, et al. Maternal methadone use in pregnancy: factors associated with the development of neonatal abstinence syndrome and implications for healthcare resources. BJOG 2009; 116: 665-71.
4. Mactier H. The management of heroin misuse in pregnancy: time for a rethink? Arch Dis Child Fetal Neonatal Ed 2011; 96: F457-60.
5. Gill AC, Oei J, Lewis NL, et al. Strabismus in infants of opiate-dependent mothers. Acta Paediatrica 2003; 92: 379-85. (Pubitemid 36408094)
6. Mulvihill AO, Cackett PD, George ND, et al. Nystagmus secondary to drug exposure in utero. Br J Ophthalmol 2007; 91: 613-15. (Pubitemid 46716528)
7. Hamilton R, McGlone L, MacKinnon JR, et al. Ophthalmic, clinical and visual electrophysiological findings in children born to mothers prescribed substitute methadone in pregnancy. Br J Ophthalmol 2010; 94: 696-700.
8. McGlone L, Mactier H, Weaver LT. Drug misuse in pregnancy: losing sight of the baby? Arch Dis Child 2009; 94: 708-12.
9. Spiteri Cornish K, Hrabovsky M, Scott NW, et al. The short- and long-term effects on the visual system of children following exposure to maternal substance misuse in pregnancy. Am J Ophthalmol 2013; 156: 190-4.
10. Konijnenberg C, Melinder A. Neurodevelopmental investigation of the mirror neurone syndrome in children of women receiving opioid maintenance therapy during pregnancy. Addiction 2012; 108: 154-60.
11. Taylor MJ, McCulloch DL. Visual evoked potentials in infants and children. J Clin Neurophysiol 1992; 9: 357-72.
12. McGlone L, Hamilton R, McCulloch DL, et al. Neonatal visual evoked potentials in infants born to mothers prescribed methadone. Pediatrics 2013; 131: e857-63.
13. McGlone L, Mactier H, Hassan H, et al. In utero drug and alcohol exposure in infants born to mothers prescribed maintenance methadone. In press: accepted for publication in Arch Dis Child 2013; 98: F542-4.
14. Gareri J, Lynn H, Handley M, et al. Prevalence of fetal ethanol exposure in a regional population-based sample by meconium analysis of fatty acid ethyl esters. Ther Drug Monit 2008; 30: 239-45. (Pubitemid 351521655)
15. Atkinson J, Anker S, Rae S, et al. A test battery of child development for examining functional vision (ABCDEFV). Strabismus 2002; 10: 245-69. (Pubitemid 36760296)
16. Sharma P, Bairagi D, Sachdeva MM, et al. Comparative evaluation of teller and cardiff acuity tests in normals and unilateral amblyopes in under-two-year-olds. Indian J Ophthalmol 2003; 51: 341-5. (Pubitemid 38082264)
17. Al-Bagdady M, Murphy PJ, Woodhouse JM, et al. Development and distribution of refractive error in children with Down's syndrome. Br J Ophthalmol 2011; 95: 1091-7.
18. Woodhouse JM, Cregg M, Gunter HL, et al. The effect of age, size of target, and cognitive factors on accommodative responses of children with Down syndrome. Invest Ophthalmol Vis Sci 2000: 41: 2479-85. (Pubitemid 30624373)
19. Odom JV, Bach M, Brigell M, et al. ISCEV standard for clinical visual evoked potentials (2009 update). Doc Ophthalmol 2010; 120: 111-19.
20. Pathai S, Cumberland PM, Rahi JS, et al. Prevalence of and early life influences on childhood strabismus: findings from the Millenium cohort study. Arch Pediatr Adolesc Med 2010; 164: 250-7.
21. Sarvananthan N, Surendran M, Roberts EO, et al. The prevalence of nystagmus: the Leicestershire nystagmus survey. Invest Ophthalmol Vis Sci 2009; 50: 5201-6.
22. Saunders KJ, Brown G, McCulloch DL. Pattern onset visual evoked potentials: more useful than reversal for patients with nystagmus. Doc Ophthalmol 1998; 94: 265-74.
23. Richards M, Wong A, Foeller P, et al. Duration of binocular decorrelation predicts the severity of latent (fusion maldevelopment) nystagmus in strabismic macaque monkeys. Invest Ophthalmol Vis Sci 2008; 49: 1872-8.
24. Tychsen L, Richards M, Wong A, et al. The neural mechanism for latent (fusion maldevelopment) nystagmus. J Neuroophthalmol 2010; 30: 276-83.
25. Hennekens CH, Buring JE. Epidemiology in medicine. Lippincott Williams and Wilkins 1987: 39-43.
26. Guo HZ, Enters EK, McDowell KP, et al. The effects of prenatal exposure to methadone on neurotransmitters in neonatal rats. Brain Res Dev Brain Res 1990; 57: 296-8.
27. Wu VW, Mo Q, Yabe T, et al. Perinatal opioids reduce straital nerve growth factor content in rat striatum. Eur J Pharmacol 2001; 414: 211-14. (Pubitemid 32181888)
28. Pertschuk LP, Sher JH, Ford DH. A morphological comparison of the regional distribution of methadone in human and rat brain as demonstrated by immunofluorescence. Drug Alcohol Depend 1976; 1: 247-54.
29. Mattick RP, Kimber J, Breen C, et al. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev 2008; (2): CD002207.
30. Jones HE, Kaltenbach K, Heil SH, et al. Neonatal abstinence syndrome after methadone or buprenorphine exposure. N Engl J Med 2010; 363: 2320-31.
31. Whitham JN, Spurrier NJ, Sawyer MG, et al. The effects of prenatal exposure to buprenorphine or methadone on infant visual evoked potentials. Neurotoxicol Teratol 2010; 32: 280-8.